Botulism Antitoxin

U.S. Department of Health and Human Services awards BioShield contract for botulism antitoxin

Published in Bioterrorism Week, June 19th, 2006

The U.S. Department of Health and Human Services (HHS) awarded a contract to the Cangene Corporation of Winnipeg, Canada in the amount of $362,641,105 for 200,000 doses of Heptavalent Botulism Antitoxin. The contract runs for five years with product delivery to the Strategic National Stockpile scheduled to begin next year.

"Botulinum toxin is one of the most poisonous substances known to science," said Dr. Gerald Parker, U.S. HHS Acting Assistant Secretary for Public Health Emergency Preparedness. "The Project BioShield contract award is part of our effort to protect the American public from biological threats."

The number of doses being purchased...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Bioterrorism Week

Source: Bioterrorism Week (2006-06-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry